On Tuesday, Acelyrin Inc (NASDAQ: SLRN) opened lower -5.36% from the last session, before settling in for the closing price of $4.29. Price fluctuations for SLRN have ranged from $3.36 to $8.89 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 53.13% at the time writing. With a float of $73.04 million, this company’s outstanding shares have now reached $99.94 million.
Let’s determine the extent of company efficiency that accounts for 130 employees. In terms of profitability, gross margin is -31.93%, operating margin of -202203.61%, and the pretax margin is -159280.12%.
Acelyrin Inc (SLRN) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Acelyrin Inc is 27.20%, while institutional ownership is 69.53%. The most recent insider transaction that took place on Jul 17 ’24, was worth 7. In this transaction Director of this company sold 1 shares at a rate of $6.86, taking the stock ownership to the 2,999 shares. Before that another transaction happened on Apr 01 ’24, when Company’s Chief Executive Officer sold 9,961 for $6.63, making the entire transaction worth $66,024. This insider now owns 1,577,374 shares in total.
Acelyrin Inc (SLRN) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.43 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 53.13% per share during the next fiscal year.
Acelyrin Inc (NASDAQ: SLRN) Trading Performance Indicators
Check out the current performance indicators for Acelyrin Inc (SLRN). In the past quarter, the stock posted a quick ratio of 7.15.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.68, a number that is poised to hit -0.85 in the next quarter and is forecasted to reach -2.04 in one year’s time.
Technical Analysis of Acelyrin Inc (SLRN)
Looking closely at Acelyrin Inc (NASDAQ: SLRN), its last 5-days average volume was 0.59 million, which is a drop from its year-to-date volume of 0.99 million. As of the previous 9 days, the stock’s Stochastic %D was 13.74%. Additionally, its Average True Range was 0.33.
During the past 100 days, Acelyrin Inc’s (SLRN) raw stochastic average was set at 18.72%, which indicates a significant increase from 3.02% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 52.52% in the past 14 days, which was lower than the 80.87% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.28, while its 200-day Moving Average is $5.35. However, in the short run, Acelyrin Inc’s stock first resistance to watch stands at $4.24. Second resistance stands at $4.41. The third major resistance level sits at $4.52. If the price goes on to break the first support level at $3.96, it is likely to go to the next support level at $3.85. Should the price break the second support level, the third support level stands at $3.68.
Acelyrin Inc (NASDAQ: SLRN) Key Stats
There are currently 100,326K shares outstanding in the company with a market cap of 407.32 million. Presently, the company’s annual sales total 0 K according to its annual income of -381,640 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -48,550 K.
